CLEARIENT Trademark

Trademark Overview

On Friday, August 6, 2021, a trademark application was filed for CLEARIENT with the United States Patent and Trademark Office. The USPTO has given the CLEARIENT trademark a serial number of 90870084. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, May 31, 2024. This trademark is owned by Honeybrains Biotech LLC. The CLEARIENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological and psychiatric conditions
clearient

General Information

Serial Number90870084
Word MarkCLEARIENT
Filing DateFriday, August 6, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, May 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological and psychiatric conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHoneybrains Biotech LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10075
Party NameHoneybrains Biotech LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10075

Trademark Events

Event DateEvent Description
Tuesday, August 10, 2021NEW APPLICATION ENTERED
Thursday, September 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 5, 2022ASSIGNED TO EXAMINER
Thursday, May 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 1, 2023SOU EXTENSION 1 FILED
Thursday, February 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 22, 2023SOU EXTENSION 1 GRANTED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 2, 2023SOU EXTENSION 2 FILED
Wednesday, August 2, 2023SOU EXTENSION 2 GRANTED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024PETITION TO REVIVE-GRANTED
Tuesday, February 6, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 6, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, February 6, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, April 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 31, 2024SOU EXTENSION 3 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

clearient psychiatric conditions neurological treatment preparations pharmaceutical